Collegium Pharmaceutical, Inc. Public Float
Collegium Pharmaceutical, Inc. (COLL) had Public Float of $926.40 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $926.40M.
- 2024-06-28: Entity Public Float $1.03B.
- 2023-06-30: Entity Public Float $741.80M.
- 2022-06-30: Entity Public Float $599.60M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $926.40M 10-K · filed 2026-02-26 |
| 2024-06-28 | $1.03B 10-K · filed 2025-02-27 |
| 2023-06-30 | $741.80M 10-K · filed 2024-02-22 |
| 2022-06-30 | $599.60M 10-K · filed 2023-02-23 |
| 2021-06-30 | $831.00M 10-K · filed 2022-02-24 |
| 2020-06-30 | $598.60M 10-K · filed 2021-02-25 |
| 2019-06-30 | $416.00M 10-K · filed 2020-02-27 |
| 2018-06-30 | $725.00M 10-K · filed 2019-02-27 |
| 2017-06-30 | $272.00M 10-K · filed 2018-03-07 |
| 2016-06-30 | $197.00M 10-K · filed 2017-03-10 |
| 2015-06-30 | $189.00M 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |